Morgane Vanbiervliet

Dr. Morgane Vanbiervliet currently holds the position of Director Global Business Development and Licensing at Debiopharm, a biopharmaceutical company in Lausanne Switzerland. Having joined Debiopharm in 2008, her collaborative work with medical, clinical and scientific teams supported early stage and clinical development of programs mainly for antivirals against HCV and antibiotics. Notably, she contributed to the successful acquisition of afabicin and related technology that led to the discovery of Debio 1453 and Debio 1455. Dr. Vanbiervliet graduated from the French engineering school ENSAR in Rennes. She holds a PhD degree in Virology from University Rennes 1.